Stable Mammalian Serum Albumins Designed for Bacterial Expression.
PROSS
animal free
phylogenetic analysis
protein design
rosetta
Journal
Journal of molecular biology
ISSN: 1089-8638
Titre abrégé: J Mol Biol
Pays: Netherlands
ID NLM: 2985088R
Informations de publication
Date de publication:
01 09 2023
01 09 2023
Historique:
received:
21
03
2023
revised:
18
06
2023
accepted:
20
06
2023
medline:
15
8
2023
pubmed:
30
6
2023
entrez:
29
6
2023
Statut:
ppublish
Résumé
Albumin is the most abundant protein in the blood serum of mammals and has essential carrier and physiological roles. Albumins are also used in a wide variety of molecular and cellular experiments and in the cultivated meat industry. Despite their importance, however, albumins are challenging for heterologous expression in microbial hosts, likely due to 17 conserved intramolecular disulfide bonds. Therefore, albumins used in research and biotechnological applications either derive from animal serum, despite severe ethical and reproducibility concerns, or from recombinant expression in yeast or rice. We use the PROSS algorithm to stabilize human and bovine serum albumins, finding that all are highly expressed in E. coli. Design accuracy is verified by crystallographic analysis of a human albumin variant with 16 mutations. This albumin variant exhibits ligand binding properties similar to those of the wild type. Remarkably, a design with 73 mutations relative to human albumin exhibits over 40 °C improved stability and is stable beyond the boiling point of water. Our results suggest that proteins with many disulfide bridges have the potential to exhibit extreme stability when subjected to design. The designed albumins may be used to make economical, reproducible, and animal-free reagents for molecular and cell biology. They also open the way to high-throughput screening to study and enhance albumin carrier properties.
Identifiants
pubmed: 37385581
pii: S0022-2836(23)00290-5
doi: 10.1016/j.jmb.2023.168191
pii:
doi:
Substances chimiques
Disulfides
0
Serum Albumin
0
Serum Albumin, Human
ZIF514RVZR
Recombinant Proteins
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
168191Subventions
Organisme : European Research Council
ID : 815379
Pays : International
Informations de copyright
Copyright © 2023 Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: O.K. and S.J.F. are named inventors in a patent application filed by Weizmann Institute of Science on the stabilized albumin variants. SJF is a paid consultant to companies that apply protein design algorithms.